BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 171 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,740,229 | +55.0% | 179,759 | +1.1% | 0.01% | +100.0% |
Q2 2023 | $3,058,762 | +113524.1% | 177,835 | +9.5% | 0.00% | 0.0% |
Q1 2023 | $2,692 | +123.8% | 162,387 | +2.8% | 0.00% | +50.0% |
Q4 2022 | $1,203 | -99.9% | 157,939 | +3.7% | 0.00% | 0.0% |
Q3 2022 | $1,514,000 | +18.3% | 152,304 | +8.0% | 0.00% | 0.0% |
Q2 2022 | $1,280,000 | +2.2% | 141,011 | +14.2% | 0.00% | 0.0% |
Q1 2022 | $1,253,000 | -41.0% | 123,491 | -3.0% | 0.00% | -33.3% |
Q4 2021 | $2,124,000 | -64.7% | 127,332 | -0.7% | 0.00% | -62.5% |
Q3 2021 | $6,010,000 | -22.0% | 128,231 | +1.4% | 0.01% | -20.0% |
Q2 2021 | $7,710,000 | +20.9% | 126,476 | +22.2% | 0.01% | +11.1% |
Q1 2021 | $6,377,000 | -2.5% | 103,519 | +12.5% | 0.01% | 0.0% |
Q4 2020 | $6,542,000 | +90.7% | 91,994 | +0.6% | 0.01% | +80.0% |
Q3 2020 | $3,430,000 | -7.1% | 91,417 | -19.3% | 0.01% | -16.7% |
Q2 2020 | $3,692,000 | +21.0% | 113,232 | +7.6% | 0.01% | 0.0% |
Q1 2020 | $3,052,000 | +208.6% | 105,246 | +272.8% | 0.01% | +200.0% |
Q4 2019 | $989,000 | +87.7% | 28,228 | +15.1% | 0.00% | +100.0% |
Q3 2019 | $527,000 | – | 24,532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |